Back to User profile » Dr Li Jiang
Papers published by Dr Li Jiang:
Therapy for Hormone Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Metastatic Breast Cancer Following Treatment Progression via CDK4/6 Inhibitors: A Literature Review
Ye M, Xu H, Ding J, Jiang L
Breast Cancer: Targets and Therapy 2024, 16:181-197
Published Date: 10 April 2024
Validation of the Prognostic Stage from the American Joint Committee on Cancer 8th Staging Manual in Luminal B-Like Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer
Ding J, Jiang L, Xu Z, Chen Y, Wu W, Huang J
Cancer Management and Research 2022, 14:719-728
Published Date: 21 February 2022
Interpectoral Lymph Node Dissection Can Be Spared in pN0/N1 Invasive Breast Cancer Undergoing Modified Radical Mastectomy: Single-Institution Experience from Mainland China
Yan Y, Jiang L, Fang J, Dai Y, Chenyu X, Ding J
Cancer Management and Research 2021, 13:5855-5863
Published Date: 27 July 2021
High Systemic Immune-Inflammation Index Predicts Poor Survival in Patients with Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer Receiving Adjuvant Trastuzumab
Jiang L, Fang J, Ding J
Cancer Management and Research 2020, 12:475-484
Published Date: 21 January 2020